Metabolic engineering to enhance biosynthesis of both docosahexaenoic acid and odd-chain fatty acids in Schizochytrium sp. S31

[1] Calder PC(2015)Functional roles of fatty acids and their effects on human health Jpen-Parenter Enter 39 18s-32s

[2] Forouhi NG(2014)Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study Lancet Diabetes Endo 2 810-818

[3] Koulman A(1989)Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis Proc Natl Acad Sci USA 86 4720-4724

[4] Sharp SJ(2015)A review of odd-chain fatty acid metabolism and the role of pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0) in health and disease Molecules 20 2425-2444

[5] Imamura F(2012)Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk Prospective Study Plos Med 9 e1001255-2219

[6] Kroger J(2014)Efficient odd straight medium chain free fatty acid production by metabolically engineered Biotechnol Bioeng 111 2209-1070

[7] Schulze MB(2005)Dependence of biodiesel fuel properties on the structure of fatty acid alkyl esters Fuel Process Technol 86 1059-1364

[8] Holman RT(2008)“Designer” biodiesel: optimizing fatty ester (composition to improve fuel properties Energy Fuel 22 1358-417

[9] Johnson SB(2018)Optimization of odd chain fatty acid production by Biotechnol Biofuels 11 158-608

[10] Kokmen E(2006)Factors affecting odd- and branched-chain fatty acids in milk: a review Anim Feed Sci Tech 131 389-214

[1] Calder PC(2015)Functional roles of fatty acids and their effects on human health Jpen-Parenter Enter 39 18s-32s

[2] Forouhi NG(2014)Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study Lancet Diabetes Endo 2 810-818

[3] Koulman A(1989)Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis Proc Natl Acad Sci USA 86 4720-4724

[4] Sharp SJ(2015)A review of odd-chain fatty acid metabolism and the role of pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0) in health and disease Molecules 20 2425-2444

[5] Imamura F(2012)Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk Prospective Study Plos Med 9 e1001255-2219

[6] Kroger J(2014)Efficient odd straight medium chain free fatty acid production by metabolically engineered Biotechnol Bioeng 111 2209-1070

[7] Schulze MB(2005)Dependence of biodiesel fuel properties on the structure of fatty acid alkyl esters Fuel Process Technol 86 1059-1364

[8] Holman RT(2008)“Designer” biodiesel: optimizing fatty ester (composition to improve fuel properties Energy Fuel 22 1358-417

[9] Johnson SB(2018)Optimization of odd chain fatty acid production by Biotechnol Biofuels 11 158-608

[10] Kokmen E(2006)Factors affecting odd- and branched-chain fatty acids in milk: a review Anim Feed Sci Tech 131 389-214